Navigation Links
Penn study finds pro-death proteins required to regulate healthy immune function
Date:8/13/2007

PHILADELPHIA Researchers at the University of Pennsylvania School of Medicine have found that proteins known to promote cell death are also necessary for the maturation and proliferation of immune cells. Activation of T-cell receptors on the surface of lymphocytes by foreign antigens initiate a calcium-mediated signaling pathway that ends in cell differentiation and growth. The Penn scientists discovered that in the cells that lack the pro-death proteins Bax and Bak, calcium signaling is disrupted and energy production is reduced. Restoration of Bax corrects the signaling problems, increases energy production, and stimulates cell division.

The results, published online in the journal Immunity, bolster the teams hypothesis that metabolic cell activity directly controls life and death decisions in cells. This issue also includes a related commentary by the studys lead author, Russell Jones, PhD, and senior author Craig B. Thompson, MD.

It is well known that cells that lack Bax (Bcl-2-associated X protein) and Bak (Bcl-2-antagonist/killer) continue living under conditions that would cause normal cells to undergo programmed cell death or apoptosis. What is less well understood, is why lymphocytes missing these key proteins are unable to trigger a strong immune response and do not proliferate as normal in response to stimulation.

We simply say they are the same thing, says Thompson, Director of the Abramson Cancer Center and Chairman and Professor of Cancer Biology and Medicine. The molecular basis of both findings is based on how Bax and Bak work on intracellular membranes.

Specifically, the team found that when the T-cell receptor was stimulated on mutant cells lacking both proteins, proliferation was severely reduced relative to normal cells. Closer investigation showed that the amount and rate of calcium release from intracellular stores was altered in the mutant cells.

The inadequate calcium signals were unable to
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... of the antioxidant urate to protect against the ... on more than urate,s ability to protect against ... the open-access journal PLoS One , researchers ... describe experiments suggesting the involvement of a novel ... against Parkinson,s-like damage. , "Our experiments showed, ...
(Date:5/23/2012)... A new study at Karlstad University in Sweden shows ... by our bodies. Phthalates are substances suspected to cause ... in children. The study shows that children can ingest ... and through the skin. , Phthalates are a group ... a great number of common consumer goods such as ...
(Date:5/23/2012)... ATS 2012, SAN FRANCISCO The number of viral ... in childhood, according to a new study from researchers ... infancy predicted wheezing later in childhood, this association was ... , "Viral infections in infancy, particularly rhinovirus, are thought ... but it is unclear whether this association is due ...
(Date:5/22/2012)... imaging (MRI) provides an indication of a breast ... possible through clinical examination, according to a new ... . , Women with breast cancer often ... that women who receive this treatment, known as ... conservation than those receiving chemotherapy after surgery. , ...
(Date:5/22/2012)... The University of Kentucky Markey Cancer Center has received ... and bone marrow disease often caused by chemotherapy or ... P. Evans Foundation, along with a $1.25 million donor ... The Evans Foundation grant will fund five research labs ... at Cincinnati Children,s Hospital, and one at the University ...
Breaking Medicine News(10 mins):Health News:Study supports urate protection against Parkinson's disease, hints at novel mechanism 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3
... The in-depth report examining internet pharmacies and life-saving ... EAASM at the 4th Global Forum ... Washington DC., WASHINGTON, June 5 The ... today unveiled its comprehensive research report,-- The Counterfeiting ...
... as Study Lends Scientific ... Arthritis Pain, SPARTA, Mich., June 5 Consumers who ... yet hesitate,to pay the premium price functional juices often command, ... Brand,s 100%,Pure Tart Cherry juice product has been added to ...
... for the World,s Longest Indoor Stair Climb Benefiting,the Damon ... Registration for Go Vertical,Chicago 2008, the annual charitable stair ... 9 a.m. CDT Tuesday, June 10 at http://www.goverticalchicago.org ... place on the morning of,November 9th, 2008, is limited ...
... Cornerstone Events of National Health IT Week, June ... through IT, WASHINGTON, June 5 The ... Information and Management,Systems Society:, (Logo: http://www.newscom.com/cgi-bin/prnh/20060801/CGTU009LOGO-a ... http://www.himsssummit.org/ ) will be held June 9-10,2008. ...
... Institution,s Department of Embryology, has been awarded the 2008 ... in recognition of his contributions to fruit fly genomics ... reproduction." The prize, which consists of a gold ... the International Congress of Genetics in Berlin on July ...
... Society, AKRON, Ohio, June 5 In an ... LLC (VHT) is proud to participate in,the American Cancer ... at Copley High School., (Logo: http://www.newscom.com/cgi-bin/prnh/20070619/CLTU033LOGO ... are expected to diagnose,more than 1.3 million new cancer ...
Other Medicine News:Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 3Health News:Reported Health Benefits of Tart Cherry Boosts Juice Distribution in Southern U.S. 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 3Health News:HIMSS Summit08 and Advocacy Day 2Health News:2008 Gruber Genetics Prize awarded to Allan Spradling of Carnegie Institution 2Health News:Virtual Hold Technology to Support Relay for Life of Westside 2
(Date:5/23/2012)... 2012  Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical ... for its U.S. phase 2 clinical trial, T ... G reater E fficacy T rial ... in patients with non-tuberculous mycobacterial (NTM) lung disease. ... to support current NTM treatment recommendations, and no new ...
(Date:5/23/2012)... Calif., May 23 2012  Isis Pharmaceuticals, Inc. ... webcast:What:Data from KYNAMRO™ presented at EAS 2012When:Friday, June ... PTWhere:www.isispharm.comHow:Live on the Internet.  Simply log onto our ... to participate during the live event, a replay ... limited time at www.isispharm.com . ...
(Date:5/23/2012)... 2012 Reportlinker.com announces that a new ... The Medical Device Market: ... Summary Espicom,s in-depth medical ... to understand the key drivers in medical markets ... data. Each report opens with an outlook section ...
Breaking Medicine Technology:Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5The Medical Device Market: USA 2The Medical Device Market: USA 3The Medical Device Market: USA 4The Medical Device Market: USA 5The Medical Device Market: USA 6The Medical Device Market: USA 7The Medical Device Market: USA 8Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 1Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 2Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 3Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 1Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 2Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 3Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 4Internet Can Help Curb Drinking Among College Students 57382 1Internet Can Help Curb Drinking Among College Students 57382 2
... today,announced the completion of 6 month follow-up on 20 ... a 78% reduction in Oswestry Disability,Index (ODI) scores, and ... leg pain. Geoff Pardo, President & CEO for Facet ... which thus far not,only demonstrate significant pain relief but ...
... WASHINGTON and MENLO PARK, Calif., Oct. 10 ,XTENT, ... it plans to present,long-term follow-up data from the ... at the Cardiovascular Research Foundation,s (CRF) twentieth annual,Transcatheter ... clinical trials are prospective studies designed to investigate,the ...
Other Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2
... onlays are pre-cut and pre-shaped to facilitate ... more frequently done. These pre-shaped onlays are ... Ultra and are designed for use in ... both small and large sizes, they provide ...
... and soft tissue reconstructions, and in ... is sometimes necessary to encourage host ... minimizing tissue attachment along another surface.,GORE ... ePTFE sheet material that offers a ...
... is pleased to announce the latest advancement ... E/X mesh.,When Bard Composix mesh was introduced ... hernia repair prosthesis that combined two clinically ... in one product. Bard Composix E/X mesh, ...
... introduction in 1958, Bard mesh has become ... are compared. Bard mesh was used by ... the "tension-free" hernia repair many years ago. ... and ideal" substance for permanent reinforcement of ...
Medicine Products: